Durvalumab With or Without Tremelimumab in Treating Participants With Stage II-IVA Oropharyngeal Squamous Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Durvalumab
Related studies linked through entity extraction aliases.
Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Durvalumab and Tremelimumab for Adjuvant Therapy of Resected NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE2
A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Durvalumab (MEDI4736) Plus Tremelimumab for Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung Origin
- Status
- COMPLETED
- Phase
- PHASE2
Durvalumab in HIV-1 Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Biomarker-based Study in R/M SCCHN
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
SGI-110 Plus Durvalumab/Tremelimumab in SCLC
- Status
- COMPLETED
- Phase
- PHASE1
Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma
- Status
- TERMINATED
- Phase
- PHASE2
Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II Study of Durvalumab in Combination With Lenalidomide in Relapsed/Refractory NK-T-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Durvalumab, Cetuximab and Radiotherapy in Head Neck Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Durvalumab in Patients With BR PDA Following Neoadjuvant Therapy and Successful Surgical Resection
- Status
- WITHDRAWN
- Phase
- PHASE2
Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2